跳至主要内容
临床试验/NCT06305130
NCT06305130已完成不适用

Prognostic Value of Eastern Cooperative Oncology Group Performance Status and American Society of Anesthesiologists Score in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

Kaohsiung Medical University0 个研究点目标入组 2,515 人开始时间: 2024年3月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,515
主要终点
Overall survival

研究概览

简要总结

Aim: to comprehensively evaluate the prognostic value of preoperative ECOG-PS scores and ASA scores in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.

Methods: multicentered cohort study

详细描述

Background:

The Eastern Cooperative Oncology Group (ECOG) performance status (PS) score and the American Society of Anesthesiologists (ASA) score are essential tools for the assessment of patients with various malignancies. However, doubts have arisen regarding their prognostic utility due to conflicting findings in limited studies. This study aims to comprehensively evaluate the prognostic value of preoperative ECOG-PS scores and ASA scores in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.

Materials and Methods

This multicentered cohort study enrolled patients who underwent RNU with curative intentat sixteen institutes in Taiwan from 1988 to 2023. Univariable and multivariable regression analyses were used to determine the impact of ECOG-PS scores and ASA scores on survival outcomes and postoperative complications. Patients were categorized based on ECOG-PS scores (0-1 vs. 2-4) and ASA scores (1-2 vs.3-4) according to prior literature.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients received UTUC surgery and follow-up in sixteen institutions across Taiwan

排除标准

  • Treatment not aimed at curative intent
  • Incomplete data

结局指标

主要结局

Overall survival

时间窗: 1988 to 2023

in days

Disease-free survival

时间窗: 1988 to 2023

in days

Bladder recurrence-free survival

时间窗: 1988 to 2023

in days

Cancer-specific survival

时间窗: 1988 to 2023

in days

次要结局

  • Number of patients with postoperative renal failure(1988 to 2023)
  • Number of patients with major postoperative complication(1988 to 2023)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hsin-Chih Yeh

Principal investigator

Kaohsiung Medical University

相似试验